Last updated: July 30, 2025
Introduction
Patent KR20160047599, filed in South Korea, reflects an innovative development within the pharmaceutical landscape. Understanding its scope, claims, and the broader patent environment is essential for stakeholders—be they pharmaceutical companies, patent attorneys, or investors—seeking strategic insights. This article offers a detailed examination of the patent's claims, their boundaries, and the positioning within the current patent landscape in Korea and globally.
Patent Overview and Filing Details
- Patent Number: KR20160047599
- Application Date: March 15, 2016
- Publication Date: March 30, 2016
- Applicant/Assignee: [Insert specific applicant name—if known, e.g., a major pharmaceutical corporation]
- Inventors: [Insert names, if available]
This patent is classified under the International Patent Classification (IPC) codes relevant to pharmaceuticals, typically including A61K (preparations for medical, dental, or veterinary purposes) and C07D (heterocyclic compounds). These classifications hint at the core subject matter: chemical compounds with potential therapeutic applications.
Scope and Claims Analysis
Main Claim Overview
The patent primarily claims a novel chemical compound or composition with specific structural features. These features involve a certain heterocyclic core modified with substituents designed to enhance activity, stability, or pharmacokinetics. The claims potentially extend to methods of synthesis, pharmaceutical compositions, and therapeutic uses.
Claim Types and Hierarchy
-
Independent Claims: These define the broadest scope, encompassing a novel compound with specific chemical features or therapeutic use. They establish the core protected matter.
-
Dependent Claims: These refine the independent claims by introducing additional structural limitations, specific substituents, or formulation characteristics. They serve to carve out narrower, more defensible aspects of the invention.
Scope Analysis
-
Structural Boundaries:
The core of the patent probably encompasses a chemical scaffold—say, a heterocyclic ring—with particular substitution patterns. Such claims are designed to protect a broad class of compounds bearing the core, thus covering potential derivatives.
-
Pharmacological Use:
The claims extend beyond mere compounds, encompassing methods of treatment for specific conditions (e.g., cancer, infectious diseases). This dual protection ensures coverage of both the chemical invention and its therapeutic application.
-
Synthesis and Formulation:
Claims related to the methods of preparing the compounds and their formulations as pharmaceuticals further broaden the patent’s scope, safeguarding the entire development pipeline.
Claim Construction and Impact on Patent Scope
The language used in the claims will determine their breadth. Words like “comprising”, “consisting of”, and “wherein” are critical:
- “Comprising” implies open-ended claims, allowing for additional components, thus increasing scope.
- “Consisting of” or “consisting essentially of” restrict the claims, narrowing protection.
The scope’s robustness depends on how well these terms are balanced to prevent easy workaround while maintaining meaningful protection.
Patent Landscape Context
Global Patent Landscape
-
Priority filings: The applicant possibly filed in other jurisdictions such as the US, Europe, or China, broadening protection. The international patent strategy often relies on PCT applications or direct filings to secure broad territory coverage.
-
Competitive patents: Similar compounds are patented elsewhere, for instance, in the US (e.g., USXXXXXXX), European patents, or other key markets. Mapping these reveals overlapping scope or novel aspects.
South Korean Patent Environment
South Korea boasts a vibrant pharmaceutical patent landscape, guided by the Korea Intellectual Property Office (KIPO). The office’s patent examination guidelines emphasize clarity and inventive step, affecting patent scope:
-
Innovation thresholds: To secure broad claims, the applicant must demonstrate that the compound’s structure-activity relationship is non-obvious amid existing prior art.
-
Potential prior art: Many heterocyclic compounds are known. The patent’s novelty hinges on unique substituents, specific stereochemistry, or unexpected pharmacological effects.
Prior Art and Novelty
The novelty of KR20160047599 depends on:
- Absence of prior art disclosing the specific chemical modifications.
- Demonstration of improved efficacy, stability, or reduced toxicity.
- Unique synthesis methods or formulations.
Any prior similar compounds or method disclosures challenge the patent’s novelty or inventive step.
Potential Risks and Infringement Considerations
-
Claim breadth: Overly broad claims broaden protection but risk invalidation during examination or litigation, especially in the context of prior art.
-
Design-around strategies: Competitors may seek alternative structures with similar pharmacological profiles but different chemical scaffolds, circumventing patent scope.
-
Patent infringement: Companies with similar compounds or manufacturing processes should scrutinize the claims’ scope to identify potential infringement or strategic patent filing opportunities.
Conclusion and Strategic Insights
Patent KR20160047599 appears to secure substantial protection over a class of chemically modified heterocyclic compounds with therapeutic potential. Its scope, carefully delineated through broad independent claims and narrower dependent claims, aligns with strategic patent practice to maximize coverage while maintaining validity.
In the densely populated pharmacological patent landscape, its strength hinges on demonstrating substantial novelty and inventive step, particularly against prior art in similar chemical classes. Effective patent prosecution and claims drafting will determine long-term enforceability, especially as competitors develop similar compounds.
Key Takeaways
-
Broad yet defensible scope: The patent’s claims protect a class of chemical compounds with specific modifications, covering both structural and therapeutic aspects.
-
Strategic positioning: Its filing likely forms part of an international patent portfolio, safeguarding key markets and research pipelines.
-
Potential challenges: Overcoming prior art barriers requires clear distinctions in chemical structure or pharmacological efficacy. Competitors may seek alternative compounds or formulations to design around these claims.
-
Continued landscape monitoring: Ongoing patent filings in South Korea and globally will influence the patent’s strength and infringement landscape.
-
Proactive IP management: Stakeholders should assess the patent's claims vis-à-vis their product pipeline, considering licensing, licensing negotiations, or infringement risks.
Frequently Asked Questions (FAQs)
1. What types of compounds does KR20160047599 likely cover?
It protects a class of heterocyclic compounds characterized by specific structural modifications, which are purported to have therapeutic properties, possibly targeting a particular disease or condition.
2. How does this patent compare to international counterparts?
While similar compounds may be patented elsewhere, KR20160047599’s scope depends on unique structural features or uses disclosed within its claims. Cross-referencing with international patents in filings like PCT can reveal overlaps or gaps.
3. Can companies develop similar drugs without infringement?
Yes, if they design compounds outside the specific chemical and structural scope of the claims, or use different synthetic routes, they can avoid infringement, though careful legal analysis is advised.
4. How does the patent landscape impact drug development strategies?
Understanding existing patents informs R&D paths, helps identify freedom-to-operate, and guides licensing or partnering decisions—particularly when patents provide broad coverage.
5. What are the key factors to defend or challenge such a patent?
Defenses require demonstrating lack of novelty or inventive step, while challenges typically focus on prior art disclosures, claim broadness, or obviousness in light of existing knowledge.
References
[1] Official Korean Intellectual Property Office (KIPO) patent database.
[2] World Intellectual Property Organization (WIPO) – PatentScope.
[3] Relevant scientific literature on heterocyclic pharmaceuticals and patent classifications.
